Sawai Group Holdings Co., Ltd. (4887.T)
JPY 2052.5
(2.22%)
JPY 2052.5
(2.22%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 100 Billion JPY | -1.77% |
| 2022 | 101.8 Billion JPY | 18.58% |
| 2021 | 85.85 Billion JPY | 8.51% |
| 2020 | 79.12 Billion JPY | 4.85% |
| 2019 | 75.46 Billion JPY | 18.93% |
| 2018 | 63.44 Billion JPY | -2.71% |
| 2017 | 65.21 Billion JPY | 5.32% |
| 2016 | 61.92 Billion JPY | 11.24% |
| 2015 | 55.66 Billion JPY | 24.64% |
| 2014 | 44.66 Billion JPY | 13.99% |
| 2013 | 39.18 Billion JPY | 32.69% |
| 2012 | 29.52 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 105.14 Billion JPY | 5.14% |
| 2023 FY | 100 Billion JPY | -1.77% |
| 2023 Q1 | 104.79 Billion JPY | 2.93% |
| 2023 Q2 | 108.33 Billion JPY | 3.38% |
| 2023 Q4 | 100 Billion JPY | 2.62% |
| 2023 Q3 | 97.45 Billion JPY | -10.05% |
| 2022 Q1 | 91.77 Billion JPY | 6.9% |
| 2022 FY | 101.8 Billion JPY | 18.58% |
| 2022 Q4 | 101.8 Billion JPY | 3.57% |
| 2022 Q3 | 98.29 Billion JPY | 2.19% |
| 2022 Q2 | 96.18 Billion JPY | 4.81% |
| 2021 Q2 | 81.91 Billion JPY | 3.7% |
| 2021 Q1 | 78.99 Billion JPY | -0.15% |
| 2021 FY | 85.85 Billion JPY | 8.51% |
| 2021 Q4 | 85.85 Billion JPY | 2.62% |
| 2021 Q3 | 83.66 Billion JPY | 2.13% |
| 2020 Q1 | 78.43 Billion JPY | 3.94% |
| 2020 FY | 79.12 Billion JPY | 4.85% |
| 2020 Q4 | 79.12 Billion JPY | 0.45% |
| 2020 Q2 | 80.29 Billion JPY | 2.38% |
| 2020 Q3 | 78.76 Billion JPY | -1.91% |
| 2019 Q3 | 74.41 Billion JPY | 1.46% |
| 2019 Q1 | 67.32 Billion JPY | 6.11% |
| 2019 Q2 | 73.34 Billion JPY | 8.94% |
| 2019 Q4 | 75.46 Billion JPY | 1.4% |
| 2019 FY | 75.46 Billion JPY | 18.93% |
| 2018 Q3 | 62.39 Billion JPY | -0.84% |
| 2018 FY | 63.44 Billion JPY | -2.71% |
| 2018 Q4 | 63.44 Billion JPY | 1.7% |
| 2018 Q2 | 62.92 Billion JPY | -1.34% |
| 2018 Q1 | 63.77 Billion JPY | -2.21% |
| 2017 Q4 | 65.21 Billion JPY | -0.85% |
| 2017 FY | 65.21 Billion JPY | 5.32% |
| 2017 Q1 | 67.76 Billion JPY | 9.7% |
| 2017 Q2 | 67.17 Billion JPY | -0.87% |
| 2017 Q3 | 65.77 Billion JPY | -2.08% |
| 2016 Q3 | 60.78 Billion JPY | 3.1% |
| 2016 Q2 | 58.95 Billion JPY | 3.46% |
| 2016 FY | 61.92 Billion JPY | 11.24% |
| 2016 Q4 | 61.77 Billion JPY | 1.63% |
| 2016 Q1 | 56.98 Billion JPY | 2.37% |
| 2015 Q2 | 51.95 Billion JPY | 3.25% |
| 2015 FY | 55.66 Billion JPY | 24.64% |
| 2015 Q4 | 55.66 Billion JPY | 3.56% |
| 2015 Q3 | 53.75 Billion JPY | 3.46% |
| 2015 Q1 | 50.32 Billion JPY | 12.67% |
| 2014 Q1 | 41.75 Billion JPY | 6.56% |
| 2014 Q2 | 43.84 Billion JPY | 5.0% |
| 2014 Q3 | 43.21 Billion JPY | -1.44% |
| 2014 Q4 | 44.66 Billion JPY | 3.36% |
| 2014 FY | 44.66 Billion JPY | 13.99% |
| 2013 FY | 39.18 Billion JPY | 32.69% |
| 2013 Q4 | 39.18 Billion JPY | 5.96% |
| 2013 Q3 | 36.97 Billion JPY | 8.39% |
| 2013 Q2 | 34.11 Billion JPY | 7.69% |
| 2013 Q1 | 31.68 Billion JPY | 7.29% |
| 2012 Q3 | 28.46 Billion JPY | 0.94% |
| 2012 Q4 | 29.52 Billion JPY | 3.72% |
| 2012 Q2 | 28.2 Billion JPY | 0.0% |
| 2012 FY | 29.52 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -1388.79% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 91.734% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 13.306% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | -54.048% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -4885.058% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | -155.688% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | -482.525% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 42.742% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -3039.78% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | -372.242% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | -230.279% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | -604.14% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -832.68% |
| Tsumura & Co. | 117.61 Billion JPY | 14.976% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | -280.294% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -830.944% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 1.059% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | -416.246% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | -590.156% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | -87.024% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -5023.053% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | -378.708% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -42998.737% |
| MedRx Co., Ltd | 10 Million JPY | -999920.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -6163.403% |
| Solasia Pharma K.K. | 122 Million JPY | -81868.852% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -1573990.981% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | -390.158% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -217083.19% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | -14.567% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -4312.649% |